121 related articles for article (PubMed ID: 16306787)
1. Expression of the high-mobility group protein HMGI(Y) in gestational trophoblastic diseases.
Briese J; Radde J; Schulte HM; Sajin M; Röser K; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Jan; 25(1):65-9. PubMed ID: 16306787
[TBL] [Abstract][Full Text] [Related]
2. Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.
Bamberger AM; Makrigiannakis A; Röser K; Radde J; Carstens T; Flohr AM; Bamberger CM; Bullerdiek J; Löning T
Virchows Arch; 2003 Nov; 443(5):649-54. PubMed ID: 13680222
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1.
Briese J; Oberndörfer M; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):271-6. PubMed ID: 15968204
[TBL] [Abstract][Full Text] [Related]
4. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of the CCAAT/enhancer-binding protein C/EBP-beta in gestational trophoblastic disease.
Radde J; Löning T; Bamberger AM
Int J Gynecol Pathol; 2004 Oct; 23(4):373-7. PubMed ID: 15381907
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma expression in normal human placenta, hydatidiform mole and choriocarcinoma.
Capparuccia L; Marzioni D; Giordano A; Fazioli F; De Nictolis M; Busso N; Todros T; Castellucci M
Mol Hum Reprod; 2002 Jun; 8(6):574-9. PubMed ID: 12029076
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
Bamberger AM; Sudahl S; Wagener C; Löning T
Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
[TBL] [Abstract][Full Text] [Related]
8. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease.
Xuan YH; Choi YL; Shin YK; Ahn GH; Kim KH; Kim WJ; Lee HC; Kim SH
Histol Histopathol; 2007 Mar; 22(3):227-34. PubMed ID: 17163397
[TBL] [Abstract][Full Text] [Related]
9. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
10. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
Shih IM; Kurman RJ
Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions.
Briese J; Sudahl S; Schulte HM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2005 Jul; 24(3):265-70. PubMed ID: 15968203
[TBL] [Abstract][Full Text] [Related]
13. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
15. Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage.
Sakuragi N; Matsuo H; Coukos G; Furth EE; Bronner MP; VanArsdale CM; Krajewsky S; Reed JC; Strauss JF
J Soc Gynecol Investig; 1994; 1(2):164-72. PubMed ID: 9419766
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua.
Kommoss F; Schmidt D; Coerdt W; Olert J; Müntefering H
Int J Gynecol Pathol; 2001 Oct; 20(4):380-5. PubMed ID: 11603223
[TBL] [Abstract][Full Text] [Related]
19. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
